We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$247M
Cap. Flow
-$496M
Cap. Flow %
-48.88%
Top 10 Hldgs %
63.97%
Holding
140
New
46
Increased
31
Reduced
3
Closed
42

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$5.48M
3
OTIC
Otonomy, Inc.
OTIC
+$3.27M
4
INSM icon
Insmed
INSM
+$2.74M
5
FNSR
Finisar Corp
FNSR
+$2.04M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$14.9M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$1.64M
3
RAI
Reynolds American Inc
RAI
+$1.15M
4
AWH
Allied World Assurance Co Hld Lt
AWH
+$825K
5
MBLY
Mobileye N.V.
MBLY
+$691K

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.88%
2 Healthcare 3.4%
3 Communication Services 0.4%
4 Technology 0.31%
5 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYNE
101
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-364,300
Closed -$6.19M
ZYNE
102
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-485,900
Closed -$8.25M
OTIC
103
CALL
DELISTED
Otonomy, Inc.
OTIC
– –
-307,500
Closed -$5.79M
MNK
104
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-100,000
Closed -$4.48M
TTPH
105
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-11,500
Closed -$1.64M
TTPH
106
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-28,500
Closed -$4.06M
NYRT
107
DELISTED
New York REIT, Inc.
NYRT
– –
-2,400
Closed -$207K
MON
108
DELISTED
Monsanto Co
MON
– –
-3,000
Closed -$355K
SGBK
109
DELISTED
Stonegate Bank
SGBK
– –
-5,200
Closed -$240K
CAB
110
DELISTED
Cabela's Inc
CAB
– –
-5,000
Closed -$297K
MBLY
111
DELISTED
Mobileye N.V.
MBLY
– –
-11,000
Closed -$691K
ARIS
112
DELISTED
ARI Network Services, Inc.
ARIS
– –
-25,994
Closed -$183K
WFM
113
DELISTED
Whole Foods Market Inc
WFM
– –
-8,000
Closed -$337K
NUTR
114
DELISTED
Nutraceutical International Co
NUTR
– –
-4,996
Closed -$208K
SPNC
115
DELISTED
Spectranetics Corp
SPNC
– –
-9,000
Closed -$346K
NVET
116
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
– –
-26,000
Closed -$174K
COVS
117
DELISTED
Covisint Corporation
COVS
– –
-10,398
Closed -$29K
RAI
118
DELISTED
Reynolds American Inc
RAI
– –
-17,675
Closed -$1.15M
PNRA
119
DELISTED
Panera Bread Co
PNRA
– –
-1,560
Closed -$491K
KATE
120
DELISTED
Kate Spade & Company
KATE
– –
-20,600
Closed -$381K
ALJ
121
DELISTED
Alon USA Energy Inc
ALJ
– –
-10,398
Closed -$139K
AWH
122
DELISTED
Allied World Assurance Co Hld Lt
AWH
– –
-15,598
Closed -$825K
SPLS
123
DELISTED
Staples Inc
SPLS
– –
-25,000
Closed -$252K
FCH
124
DELISTED
Felcor Lodging Trust
FCH
– –
-25,995
Closed -$187K
SAJA
125
DELISTED
Sajan, Inc.
SAJA
– –
-15,600
Closed -$91K
2 3 4
5
6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, DLD Asset Management held 140 positions worth $1.02B, up 32% from $768M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

DLD Asset Management withdrew a net $496M in Q3 2017, closing 42 positions and reducing 3 holdings. Its most notable exit was Arista Networks, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, DLD Asset Management opened a new position in PTC Therapeutics worth $12.3M.

  • DLD Asset Management's largest Q3 2017 buy was PTC Therapeutics: 612,543 shares worth $12.3M.
  • DLD Asset Management added most to Insmed in Q3 2017, an estimated $2.74M increase.
  • DLD Asset Management's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $138K.
  • DLD Asset Management fully exited Arista Networks in Q3 2017, selling an estimated $14.9M.
  • DLD Asset Management's ten largest holdings make up 64% of its $1.02B portfolio in Q3 2017.
  • DLD Asset Management opened 46 new positions and closed 42 in Q3 2017.
  • DLD Asset Management's portfolio value rose 32% quarter-over-quarter to $1.02B.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.